Ernexa Therapeutics Inc. (ERNA) stock
ERNANasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ERNAW
$1.93−0.08 (-3.98%)
Close on Nov 11, 2026Market cap $3.15MP/E –Yield –
Ernexa Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Ernexa Therapeutics's total assets was $7.10M at Sep 30, 2026. For fiscal 2025 it was $5.83M, up 10.7% from the year before. Over ten years it grew -9.8% a year on average. The highest annual figure on record is $49.13M in fiscal 2023.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.83M | +10.7% |
| FY2024 | Dec 31, 2024 | $5.27M | -89.3% |
| FY2023 | Dec 31, 2023 | $49.13M | +120.5% |
| FY2022 | Dec 31, 2022 | $22.28M | -29.3% |
| FY2021 | Dec 31, 2021 | $31.53M | +144.3% |
| FY2020 | Dec 31, 2020 | $12.91M | -8.6% |
| FY2019 | Dec 31, 2019 | $14.13M | -5.0% |
| FY2018 | Dec 31, 2018 | $14.86M | -10.3% |
| FY2017 | Dec 31, 2017 | $16.57M | -0.7% |
| FY2016 | Dec 31, 2016 | $16.70M | +1.7% |
| FY2015 | Dec 31, 2015 | $16.41M | -26.3% |
| FY2014 | Dec 31, 2014 | $22.27M | +44.1% |
| FY2013 | Dec 31, 2013 | $15.46M | +22.1% |
| FY2012 | Dec 31, 2012 | $12.66M | +8.7% |
| FY2011 | Dec 31, 2011 | $11.65M | -11.3% |
| FY2010 | Dec 31, 2010 | $13.13M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $7.10M | +15.1% |
| Q2 FY2026 | Jun 30, 2026 | $6.32M | -16.7% |
| Q1 FY2026 | Mar 31, 2026 | $10.54M | +108.4% |
| Q4 FY2025 | Dec 31, 2025 | $5.83M | +10.7% |
| Q3 FY2025 | Sep 30, 2025 | $6.17M | -20.0% |
| Q2 FY2025 | Jun 30, 2025 | $7.58M | -83.7% |
| Q1 FY2025 | Mar 31, 2025 | $5.06M | -89.8% |
| Q4 FY2024 | Dec 31, 2024 | $5.27M | -89.3% |
| Q3 FY2024 | Sep 30, 2024 | $7.72M | -85.2% |
| Q2 FY2024 | Jun 30, 2024 | $46.49M | -1.0% |
| Q1 FY2024 | Mar 31, 2024 | $49.66M | +228.7% |
| Q4 FY2023 | Dec 31, 2023 | $49.13M | +120.5% |
| Q3 FY2023 | Sep 30, 2023 | $52.25M | +149.7% |
| Q2 FY2023 | Jun 30, 2023 | $46.95M | +74.5% |
| Q1 FY2023 | Mar 31, 2023 | $15.11M | -57.3% |
| Q4 FY2022 | Dec 31, 2022 | $22.28M | -29.3% |
| Q3 FY2022 | Sep 30, 2022 | $20.93M | -46.9% |
| Q2 FY2022 | Jun 30, 2022 | $26.90M | -58.4% |
| Q1 FY2022 | Mar 31, 2022 | $35.38M | +70.9% |
| Q4 FY2021 | Dec 31, 2021 | $31.53M | +144.3% |
| Q3 FY2021 | Sep 30, 2021 | $39.39M | +679.5% |
| Q2 FY2021 | Jun 30, 2021 | $64.71M | +853.0% |
| Q1 FY2021 | Mar 31, 2021 | $20.70M | +87.9% |
| Q4 FY2020 | Dec 31, 2020 | $12.91M | -8.6% |
| Q3 FY2020 | Sep 30, 2020 | $5.05M | -66.1% |
| Q2 FY2020 | Jun 30, 2020 | $6.79M | -56.6% |
| Q1 FY2020 | Mar 31, 2020 | $11.01M | -33.1% |
| Q4 FY2019 | Dec 31, 2019 | $14.13M | -5.0% |
| Q3 FY2019 | Sep 30, 2019 | $14.92M | -4.0% |
| Q2 FY2019 | Jun 30, 2019 | $15.64M | -4.4% |
| Q1 FY2019 | Mar 31, 2019 | $16.48M | +4.9% |
| Q4 FY2018 | Dec 31, 2018 | $14.86M | -10.3% |
| Q3 FY2018 | Sep 30, 2018 | $15.54M | -11.5% |
| Q2 FY2018 | Jun 30, 2018 | $16.36M | -11.7% |
| Q1 FY2018 | Mar 31, 2018 | $15.70M | -10.5% |
| Q4 FY2017 | Dec 31, 2017 | $16.57M | -0.7% |
| Q3 FY2017 | Sep 30, 2017 | $17.56M | – |
| Q2 FY2017 | Jun 30, 2017 | $18.53M | – |
| Q1 FY2017 | Mar 31, 2017 | $17.53M | – |
| Q4 FY2016 | Dec 31, 2016 | $16.70M | – |
See a number that looks wrong?